Preventing the progression of diabetes can help patients maintain a healthy quality of life while saving significant costs, said Fatima Cody Stanford, MD, MPH, MPA, FAAP, FTOS, of Harvard Medical School and Massachusetts General Hospital.
Preventing the progression of diabetes can help patients maintain a healthy quality of life while saving significant costs, said Fatima Cody Stanford, MD, MPH, MPA, FAAP, FTOS, of Harvard Medical School and Massachusetts General Hospital.
Transcript (slightly modified)
What is the importance of Medicare paying for the National Diabetes Prevention Program?
When you’re looking at the DPP, we’re specifically looking at diabetes, and I think that that’s important. When we look at the breadth of obesity with over 93 million patients struggling with obesity in the United States, those numbers by far surpass any other disease process. So we want to get them before we’re getting into that prediabetes or diabetic state.
We know already, for example, that most patients that have prediabetes, so a hemoglobin A1c that falls between 5.7 and 6.4, have no clue that they have prediabetes. So we’re not getting to them, they all of a sudden end up in the office and they have diabetes and they’re like, “I never knew.” But their physician may have already checked their A1c and did not inform them that they’re falling within this gray zone that’s progressing relatively rapidly to type 2 diabetes, which is the one that we can potentially have an impact on.
I think that what’s happening is that we’re so treatment-focused that we’re often forgetting that we can avoid these treatments, which are very expensive over the lifetime, and also often significantly affecting the quality of life that the patient has. If we can get to them before then, then they can have a nice, healthy quality of life without a lot of the morbidity and mortality and associated costs, if we get to them earlier.
So I think that’s really part of what we need to think about when we’re looking at the Affordable Care Act and its coverage, Medicaid and its coverage, we need to look at these things: getting to people before these disease processes become prominent, and are costly to patients for their lives, their health, et cetera.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Dr Michael Farwell on FDG PET/CT Imaging to Predict Immunotherapy Response in Advanced Melanoma
April 15th 2024Michael Farwell, MD, associate professor of radiology at the Hospital of the University of Pennsylvania, provides insights into a study on the benefits of using 18F-fluorodeoxyglucose (FDG) PET/CT imaging to detect metabolic tumor changes in skin cancer.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More